Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

Beauregard Health System has integrated Artera’s patient communication platform and [...]

VoxCell, a Canadian biotechnology company developing vascularized 3D tissue models, [...]

The START Center for Cancer Research has appointed Dr Navid [...]

Scancell Holdings has announced that the U.S. Food and Drug [...]

Milestone Pharmaceuticals has announced the commercial availability of CARDAMYST (etripamil) [...]

MaaT Pharma has reported its half year 2025 financial results, [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

Donidalorsen has received European Union marketing authorisation for the routine [...]

Soley Therapeutics has published a peer-reviewed study describing a method [...]